Key result
Self-expanding valves improve 1-month LVEF more than balloon-expandable valves but carry higher paravalvular leak risk.
Why the study?
Although self-expanding and balloon-expandable valves are widely used in transcatheter aortic valve replacement, the optimal choice in patients with reduced LVEF (<40%) remains uncertain.
Do self-expanding valves improve outcomes compared to balloon-expandable valves in patients with LVEF <40% undergoing transcatheter aortic valve replacement?
Meta-Analysis (n=5,365)
Do self-expanding valves improve outcomes compared to balloon-expandable valves in patients with LVEF <40% undergoing transcatheter aortic valve replacement?
Answers are grounded in this paper and cite their sources.
In patients with LVEF <40% undergoing TAVR, self-expanding valves may offer superior early LVEF improvement and lower aortic gradients compared to balloon-expandable valves, but are associated with a higher rate of paravalvular leaks and similar mortality.
Patients with reduced left ventricular ejection fraction (LVEF) undergoing transcatheter aortic valve replacement remain a clinically vulnerable group. Although self-expanding valves (SEVs) and balloon-expandable valves are widely used, the optimal choice in patients with LVEF <40% remains uncertain. We aimed to synthesize the available evidence comparing these two valve types in this high-risk population. We conducted a systematic review and meta-analysis of observational studies comparing SEVs and balloon-expandable valves in patients with LVEF <40% undergoing transcatheter aortic valve replacement. Outcomes included changes in LVEF, aortic gradients, mortality, and safety endpoints. Pooled estimates were calculated using random-effects models, and multivariable meta-regression was performed to adjust for study-level confounding. Five studies comprising 5365 patients were included. SEVs were associated with a greater improvement in 1-month LVEF (mean difference, 2.33; 95% confidence interval [CI], 0.83 to 3.83; p = 0.01) and lower mean aortic gradients (mean difference, -2.72; 95% CI, -3.51 to -1.93; p < 0.01). Procedural mortality (risk ratio [RR], 0.89; 95% CI, 0.26-3.11; p = 0.86), 30-day mortality (RR, 1.52; 95% CI, 0.65-3.56; p = 0.33), and 1-year mortality (RR, 1.13; 95% CI, 0.69-1.84; p = 0.44) were similar. SEVs carried an increased risk of moderate or worse paravalvular leak (RR, 2.52; 95% CI, 1.46-4.36; p < 0.01). While SEVs may offer superior early LVEF improvement, they are associated with a higher rate of paravalvular leaks. Current data are observational and insufficient to recommend one valve type over another.
No takes yet. Share an insight, caveat, or question.
Najah et al. (2026) conducted a meta-analysis in Reduced left ventricular ejection fraction (LVEF <40%) undergoing transcatheter aortic valve replacement (n=5,365). Self-expanding valves (SEVs) vs. Balloon-expandable valves was evaluated on 1-month LVEF improvement (Mean difference 2.33, 95% CI 0.83 to 3.83, p=0.01). Self-expanding valves showed greater 1-month LVEF improvement but higher paravalvular leak risk compared to balloon-expandable valves.
Synapse has enriched 10 related papers. Consider them for comparative context: